Revenue
2024
2025
| 2025 | 2024 | |
|---|---|---|
| Revenue | $462.1M | $420.6M |
| Gross profit | $260.2M | $219.2M |
| Research & development | $6.6M | $7.4M |
| Operating income | $143.3M | $126.5M |
| EBITDAderived | $151.8M | $135.7M |
| Net income | −$5.9M | −$2.3M |
| Basic EPSper diluted share | -$0.69 | -$0.27 |
| Diluted EPSper diluted share | -$0.69 | -$0.27 |
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 14, 2026Form 4 | Mikkilineni KrishnaDirector | BuyCommon Stock, par value $0.0001 per share | 921.4 | $108.52 | $100.0K | 1.1K |
| May 13, 2026Form 4 | Schoen KurtChief Financial Officer | BuyCommon Stock, par value $0.0001 per share | 450 | $108.34 | $48.8K | 2.9K |
| Mar 17, 2026Form 4 | THOMPSON JANE J.Director | SellCommon Stock, par value $0.0001 per share | 1.9K | $124.42 | $230.2K | 6.3K |
| Mar 17, 2026Form 4 | Schoen KurtChief Financial Officer | BuyCommon Stock | 500 | $141.51 | $70.8K | 2.4K |
| Mar 17, 2026Form 4 | Cote John D.Director | BuyCommon Stock, par value $0.0001 per share · indirect | 52 | $144.50 | $7.5K | 552 |